{"version": "1.2.0", "chapters": [{"title": "Intro: Reflecting on Season 3", "startTime": 0}, {"title": "(Part 1) Interview with Confluent Medical's Brittany Mai", "startTime": 322}, {"title": "Keynote Interview: Rebecca Wilkins, DVP of R&D at Abbott’s neuromodulation business", "startTime": 476}, {"title": "A Personal Connection: How DBS Impacted a Family", "startTime": 837}, {"title": "Innovation in Connectivity: Bluetooth and NeuroSphere™ Virtual Clinic", "startTime": 981}, {"title": "(Part 2) Interview with Confluent Medical's Brittany Mai", "startTime": 1297}, {"title": "Targeted Therapy: Understanding Spinal Cord and DRG Stimulation", "startTime": 1482}, {"title": "Breaking Barriers: MRI Compatibility and Device Longevity", "startTime": 1957}, {"title": "New Data from NANS: Validating Patient Outcomes", "startTime": 2164}]}